Delivery Order SPE2DB20D7059-SPE2DB26FGSA8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,668.77 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's substantial role as a pharmaceutical supplier to federal medical procurement needs. The contract is being performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $5,370.15 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Refresh Plus 0.5% eye drops (30 units). This is a non-set-aside competitive award with an ultimate completion date of October 22, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 count) valued at $4,034.24 on April 24, 2025, with completion scheduled for April 25, 2025. This competitively awarded, non-set-aside contract was issued on a firm fixed-price basis and represents a child delivery order under a larger contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,275.48 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (50-unit dose) on May 15, 2025, with an ultimate completion date of May 16, 2025. The contract is priced on a firm fixed-price basis with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Refresh Plus 0.5% eye drops in 30-unit quantities. This is a firm fixed-price delivery order with a ceiling value of $1,003.09 and an ultimate completion date of September 9, 2025. The contract does not utilize a set-aside designation and will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Refresh Plus 0.5% eye drops in 30-unit quantities. This $1,540.57 firm fixed-price contract represents a non-competitive delivery order utilizing AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded under the broader IDC vehicle (SPE2DX) valued at $999,999,999.00 and expiring in December 2026, which...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Refresh Plus 0.5% eye drops in unit dose 50-count packages. This firm fixed price delivery order, valued at $2,155.74, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award is unset-aside and will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $1,002.94 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (50-count unit dose) on September 12, 2025, with a completion date of September 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger prime contract vehicle with DLA. The work will be performed at the contractor's corporate office location in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Refresh Plus 0.5% eye drops in unit dose format (50 units) valued at $2,397.84. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a $1,317.86 delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Refresh Plus 0.5% Eye Drops (30 units). This firm fixed price delivery order, with a completion date of October 31, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB26FGSA8Delivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Refresh Plus 0.5% eye drops (30-unit packages) with a ceiling value of $1,335.90. This is a firm fixed-price delivery order with an ultimate completion date of November 5, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. This parent contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's federal procurement history demonstrates consistent competitively awarded contracts for diverse pharmaceutical products across multiple therapeutic domains, positioning it as a critical vendor in the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 11/4/25 |